Global Gastroparesis Drugs Market 2017-2021

Global Gastroparesis Drugs Market 2017-2021

  • May 2017 •
  • 70 pages •
  • Report ID: 4886908 •
  • Format: PDF

About Gastroparesis Drugs

Gastroparesis also known as delayed gastric emptying, is a disorder that stops or slows the movement of food through the digestive tract. Normally, the vagus nerve controls the stomach muscles, which are responsible for the movement of food in the stomach. These muscles contract to break up the food and lead to its movement through the gastrointestinal tract. Gastroparesis can be caused due to the damage of vagus nerve by illness or injury. The disease does not have complete remission; however, proper medications along with the changes in diet can provide relief.

Technavio’s analysts forecast the global gastroparesis drugs market to grow at a CAGR of 3.54% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global gastroparesis drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas

Technavio's report, Global Gastroparesis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Cadila Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson
• Valeant

Other prominent vendors
• Evoke Pharma
• Teva Pharmaceutical Industries
• Theravance Biopharma

Market driver
• Rising cases of diabetes fueling the prevalence of diabetic gastroparesis.
• For a full, detailed list, view our report

Market challenge
• Difficulty in diagnosis is hampering the medication process.
• For a full, detailed list, view our report

Market trend
• Introduction of novel ways for the treatment of gastroparesis symptoms.
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

We are very sorry, but an error occurred.
Please contact if the problem remains.